Vir Biotechnology, Inc. VIR Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s common stock, par value (in dollars per share)?
- Vir Biotechnology, Inc. (VIR) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Vir Biotechnology, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Vir Biotechnology, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Vir Biotechnology, Inc.'s common stock, par value (in dollars per share)?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.